Your search returned 9 results.

Results
	1.	Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycin. [electronic resource] by Fernandes, P B Ramer, N Rode, R A Freiberg, L Producer: 19880726 In: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The effect of pituitary suppression and the women's age on embryo viability and uterine receptivity. [electronic resource] by Chetkowski, R J Rode, R A Burruel, V Nass, T E Producer: 19920116 In: Fertility and sterility vol. 56 Availability: No items available. Save to lists Add to cart (remove)
	3.	Regression analysis, proposed interpretative zone size standards, and quality control guidelines for a new macrolide antimicrobial agent, A-56268 (TE-031). [electronic resource] by Hanson, C W Bailer, R Gade, E Rode, R A Fernandes, P B Producer: 19870724 In: Journal of clinical microbiology vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. [electronic resource] by Hardy, D J Swanson, R N Rode, R A Marsh, K Shipkowitz, N L Clement, J J Producer: 19900918 In: Antimicrobial agents and chemotherapy vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Identification of genotypic changes in human immunodeficiency virus protease that correlate with reduced susceptibility to the protease inhibitor lopinavir among viral isolates from protease inhibitor-experienced patients. [electronic resource] by Kempf, D J Isaacson, J D King, M S Brun, S C Xu, Y Real, K Bernstein, B M Japour, A J Sun, E Rode, R A Producer: 20010823 In: Journal of virology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at the nadir. [electronic resource] by Kempf, D J Rode, R A Xu, Y Sun, E Heath-Chiozzi, M E Valdes, J Japour, A J Danner, S Boucher, C Molla, A Leonard, J M Producer: 19980608 In: AIDS (London, England) vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. [electronic resource] by Ferguson, N M Donnelly, C A Hooper, J Ghani, A C Fraser, C Bartley, L M Rode, R A Vernazza, P Lapins, D Mayer, S L Anderson, R M Producer: 20060816 In: Journal of the Royal Society, Interface vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Gender difference in HIV-1 RNA viral loads. [electronic resource] by Donnelly, C A Bartley, L M Ghani, A C Le Fevre, A M Kwong, G P Cowling, B J van Sighem, A I de Wolf, F Rode, R A Anderson, R M Producer: 20050920 In: HIV medicine vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trial. [electronic resource] by Caterson, I D Finer, N Coutinho, W Van Gaal, L F Maggioni, A P Torp-Pedersen, C Sharma, A M Legler, U F Shepherd, G M Rode, R A Perdok, R J Renz, C L James, W P T Producer: 20120723 In: Diabetes, obesity & metabolism vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)